Sunday, October 30, 2005

Big Bad Drug Companies

The NYTimes engages in more of its typical "journalism."
"Congress Weighs Big Cuts to Medicaid and Medicare"
Craig L. Fuller, president of the National Association of Chain Drug Stores, a trade group, said he did not understand how House Republicans could cut payments to pharmacies and increase co-payments for poor people without requiring drug manufacturers to make any contribution to the savings.

But Billy Tauzin, president of the Pharmaceutical Research and Manufacturers of America, a lobbying organization for brand-name drug companies, said the price concessions required by the Senate bill could hurt Medicaid recipients and other patients by forcing drug makers to "reduce research and development of life-saving medicines."
(emphasis added)

The NASD is a trade group, whose website includes information on meetings with members of Congress about speeding up generic drug production. They're just a trade group.

But the PRMA is a "lobbyist" group (a word fraught with negative connotations). Those big bad drug companies.